RecruitingEarly Phase 1NCT07674680

Beta3-adrenergic Receptors and Cardiovascular Function in Aging Women

Sponsor

University of Missouri-Columbia

Enrollment

60 participants

Start Date

Jul 31, 2026

Study Type

INTERVENTIONAL

Conditions

Menopause Women Aging

Summary

To determine if vascular beta3 adrenergic receptors are present and functional in aging women and can be targeted to attenuate sympathetic vasoconstriction and enhance vascular function in aging women.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Gemtesa and a drug called Placebo for people with aging, menopause, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.